Validity and reliability of Korean version of Modified Fatigue Impact Scale (MFIS) for Korean patients with multiple sclerosis

Yeon Hak Chung, Ansuk Jeong, Byoung Joon Kim, Kwangbai Park, Ju Hong Min

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background: To determine the validity and reliability of the Korean version of the Modified Fatigue Impact Scale (MFIS-K) questionnaire for patients with multiple sclerosis (MS). Methods: We prospectively enrolled 52 patients with MS and 102 healthy controls. Subjects were asked to complete the Korean version of Fatigue Severity Scale (FSS) and MFIS-K. To evaluate sleep quality, depression, pain, and quality of life, patients completed the Pittsburgh Sleep Quality Index (PSQI), the Beck Depression Scale II (BDI), the Brief Pain Inventory (BPI), and the Short Form 36 Health Survey (SF-36). Results: It was demonstrated that MFIS-K has appropriate construct validity with distinctive 3 factors (cognitive, physical, and psychosocial). The criterion validity was also confirmed with the total score and the factor scores of the patients with MS, which were all significantly higher than those of healthy controls. Convergent validity of the MFIS-K was verified with the correlations with Fatigue Severity Scale (FSS) and other concurrent measures of sleep disturbances, depression, pain, and limitations in activities due to health problems. Furthermore, the internal consistency, temporal stability, and score consistency of the MFIS-K turned out acceptable. Discussion: Our results indicate that the Korean version of MFIS is a valid and reliable scale to assess fatigue in the Korean MS population.

Original languageEnglish
Article number103811
JournalMultiple Sclerosis and Related Disorders
Volume62
DOIs
StatePublished - Jun 2022

Keywords

  • Fatigue
  • Modified Fatigue Impact Scale
  • Multiple sclerosis
  • Reliability
  • Validity

Fingerprint

Dive into the research topics of 'Validity and reliability of Korean version of Modified Fatigue Impact Scale (MFIS) for Korean patients with multiple sclerosis'. Together they form a unique fingerprint.

Cite this